Study of GR2301 injection with light therapy for vitiligo
Treatments studied
Part of Skin clinical trials.
This trial tests a new medicine called GR2301, given as an injection, combined with light therapy, to see if it can help people with vitiligo. It aims to improve skin color in affected areas, especially on the face.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have non-segmental vitiligo, which is the most common type where white patches appear on both sides of the body.
- Your vitiligo must have been present for at least 3 months.
- White patches on your face must cover at least 0.5% of your facial skin, and patches on your whole body must cover at least 3% of your body.
- You must be willing to follow the study rules and give written consent to participate.
- You cannot have had permanent makeup or skin grafting in the vitiligo areas.
- You should not have any medical conditions that make light therapy unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.
This study tests a new medicine called LY4005130 for non-segmental vitiligo, a skin condition where patches lose pigment (color). The trial aims to see if this drug can help restore skin color and stop the spread of white patches.
This study tests a new medicine called FB102 for people with non-segmental vitiligo. It aims to see if the drug is safe and helps restore skin color.
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.